Home›Stock Screener›Sun Pharmaceutical›Quarterly Results

Sun Pharmaceutical Quarterly Results

Latest Quarter Net Profit
₹2,710 Cr
QMar 2026
Quarterly Results

Sun Pharmaceutical quarterly results. In Mar 2026, Sun Pharmaceutical (SUNPHARMA) reported revenue ₹15,018 Cr and net profit ₹2,710 Cr — revenue +11.8% YoY. Review SUNPHARMA PE ratio trends to evaluate earnings-based valuation against sector peers.

SUNPHARMA Quarterly Results — Revenue, Profit & EPS Highlights

Sun Pharmaceutical latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Sun Pharmaceutical stock price NSE.

  • Revenue of ₹15,018 Cr in Mar 2026 (-5.6% vs Jun 2026, +11.8% vs Mar 2025)
  • Net Profit of ₹2,710 Cr in Mar 2026 (-6.6% vs Jun 2026, +25.8% vs Mar 2025)
  • EBITDA of ₹4,361 Cr in Mar 2026 (-9.5% vs Jun 2026)
  • Operating Margin of 27.0% in Mar 2026 (+0.0pp vs Jun 2026)
  • Earnings Per Share of ₹11.30 in Mar 2026 (-6.6% vs Jun 2026)

Sun Pharmaceutical Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SUNPHARMA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 15,018 15,907 14,875 13,429 14,251 -5.6% 11.8%
Net Profit (₹ Cr) 2,710 2,901 3,125 2,154 2,293 - -
EBITDA (₹ Cr) 4,361 4,821 4,924 3,824 3,883 - -
EPS (₹) 11.30 12.10 13.00 9.00 9.50 - -
Operating Margin (%) 27.0% 27.0% 31.0% 25.0% 25.0% - -

SUNPHARMA Share Price Trend — 1-Year Movement Across Quarterly Results

Sun Pharmaceutical 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check SUNPHARMA market cap trends to track the company's total market size over time.

Profitability Ratios

Profit Margin 18.0%
EBITDA Margin 29.0%
Operating Margin 27.0%
ROE (Annual) 12.9%

Balance Sheet Highlights

Total Assets ₹108,785 Cr
Total Equity ₹83,880 Cr
Current Assets ₹ Cr
Current Liabilities ₹2,283 Cr

Cash Flow Analysis

Operating Cash Flow ₹12,419 Cr
Investing Cash Flow ₹-10,405 Cr
Financing Cash Flow ₹-2,513 Cr
Net Cash Flow ₹-498 Cr

Current Market Data

Current Price ₹1758.00
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 13,429
Sept 2025 14,875
Jun 2026 15,907
Mar 2026 15,018

Net Profit Trend (₹ Cr)

Mar 2025 2,154
Sept 2025 3,125
Jun 2026 2,901
Mar 2026 2,710

Operating Margin Trend (%)

Mar 2025 25.0%
Sept 2025 31.0%
Jun 2026 27.0%
Mar 2026 27.0%

SUNPHARMA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sun Pharmaceutical latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 9162.0 2,986 751 -5.0% - 25.2% 323.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1135.0 7,569 1,341 -4.3% - 17.7% 89.7
Cipla
Mar 2026 		₹106,152.60 Cr 1330.9 6,612 543 -9.3% - 8.2% 193.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores